M. Vance

E. Laws, M. Vance, S. Aytug, 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Fasting as a metabolic stress paradigm selectively amplifies cortisol secretory burst mass and delays the time of maximal nyctohemeral cortisol concentrations in healthy men.

A. Iranmanesh, M. Vance, M. Thorner, 1996, The Journal of clinical endocrinology and metabolism.

Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.

J. A. Scarlett, L. Phillips, M. Vance, 2000, The New England journal of medicine.

Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant.

M. Vance, W. Drake, D. Clemmons, 2005, The Journal of clinical endocrinology and metabolism.

Metabolic Status and Growth Hormone Secretion in Man

M. Vance, 1993, The Journal of pediatric endocrinology.

Long-term Outcomes After Gamma Knife Radiosurgery for Patients With a Nonfunctioning Pituitary Adenoma

E. Laws, J. Sheehan, M. Vance, 2011, Neurosurgery.

Growth Hormone Replacement Therapy in Adult Onset GH Deficiency : Effects on Body Composition in Men and Women in a Double-Blind , Randomized , Placebo-Controlled Trial

L. Phillips, A. Hoffman, M. Vance, 2005 .

Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.

L. Phillips, A. Hoffman, M. Vance, 2004, The Journal of clinical endocrinology and metabolism.

Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.

M. Vance, A. Rogol, R. Furlanetto, 1984, The Journal of clinical endocrinology and metabolism.

Immunohistochemistry of COUP-TFI: an adjuvant diagnostic tool for the identification of corticotroph microadenomas

E. Laws, M. Vance, M. Lopes, 2009, Pituitary.

Drugs Five Years Later: Bromocriptine

M. Vance, M. Thorner, W. Evans, 1984 .

Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men.

M. Vance, L. Frohman, T. Downs, 1985, The Journal of clinical endocrinology and metabolism.

Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.

M. Vance, A. Rogol, L. Frohman, 1984, The Journal of clinical endocrinology and metabolism.

Decrease of Serum IGF-I following Transsphenoidal Pituitary Surgery for Acromegaly.

D. Bruns, E. Oldfield, M. Vance, 2017, Clinical chemistry.

Management of acromegaly: Is there a role for primary medical therapy?

M. Vance, Zachary M. Bush, 2008, Reviews in Endocrine and Metabolic Disorders.

Pituitary Surgery for the Management of Acromegaly

E. Laws, M. Vance, K. Thapar, 2000, Hormone Research in Paediatrics.

Whole Sella vs Targeted Stereotactic Radiosurgery for Acromegaly: A Multicenter Matched Cohort Study.

L. Lunsford, J. Sheehan, M. Vance, 2020, Neurosurgery.

Correlation between GH and IGF-1 during treatment for acromegaly.

E. Oldfield, J. Sheehan, M. Vance, 2016, Journal of neurosurgery.

Guidelines for acromegaly management.

P. Chanson, E. Laws, F. Casanueva, 2002, The Journal of clinical endocrinology and metabolism.

Primary fibrosarcoma of the sella unrelated to previous radiation therapy.

E. Laws, M. Vance, H. Cloft, 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Estrogen Receptors in Prolactinomas: A Clinico-Pathological study

E. Laws, M. Vance, M. Lopes, 2004, Pituitary.

Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly

P. Cappabianca, A. Mamelak, R. Fahlbusch, 2017, Pituitary.

Role of Medical Therapy in the Management of Acromegaly

E. Laws, M. Vance, 2005, Neurosurgery.

A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly.

P. Chanson, M. Vance, S. Melmed, 2005, The Journal of clinical endocrinology and metabolism.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF ACROMEGALY AACE Acromegaly Guidelines Task Force Chairman

S. Ezzat, M. Vance, D. Cook, 2004 .

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF ACROMEGALY

S. Ezzat, M. Vance, D. Cook, 2004 .

Diagnosis and treatment of acromegaly complications

P. Chanson, F. Casanueva, M. Vance, 2003, Journal of endocrinological investigation.

Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin.

M. Vance, M. Thorner, J. Veldhuis, 1989, The Journal of clinical endocrinology and metabolism.

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.

M. Vance, K. Yuen, D. Cook, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Treatment of ACTH-dependent Cushing ’ s syndrome : a consensus statement

J. Bertherat, X. Bertagna, M. Vance, 2008 .

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

L. Nieman, J. Bertherat, X. Bertagna, 2008, The Journal of clinical endocrinology and metabolism.

Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man.

M. Vance, L. Frohman, W. Vale, 1984, The Journal of clinical investigation.

Fasting alters pulsatile and rhythmic cortisol release in normal man.

M. Vance, M. Thorner, 1989, The Journal of clinical endocrinology and metabolism.

Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma.

M. Vance, J. Hanks, J. Weltman, 1994, The Journal of clinical endocrinology and metabolism.

Hypogonadism in patients with acromegaly: data from the multi‐centre acromegaly registry pilot study

D. Schoenfeld, M. Vance, A. Klibanski, 2001, Clinical endocrinology.

Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy.

M. Vance, R. Furlanetto, M. Thorner, 1990, The Journal of clinical endocrinology and metabolism.

Growth-hormone-releasing hormone.

M. Vance, 1990, Clinical chemistry.

Physiological and clinical studies of GRF and GH.

M. Vance, A. Rogol, M. Thorner, 1986, Recent progress in hormone research.

Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.

M. Vance, L. Frohman, R. Furlanetto, 1985, The Journal of clinical endocrinology and metabolism.

Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.

M. Vance, L. Frohman, W. Vale, 1984, The Journal of clinical investigation.

Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype

J. Sheehan, M. Vance, Ching-Jen Chen, 2015, Pituitary.

Temporal structure of in vivo growth hormone secretory events in humans.

M. Vance, M. Thorner, J. Veldhuis, 1991, The American journal of physiology.

Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults

F. Harrell, S. Heymsfield, M. Vance, 2008, Annals of Internal Medicine.

Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults

F. Harrell, S. Heymsfield, M. Vance, 2008, Annals of Internal Medicine.

Growth hormone and cortisol secretion in patients with burn injury.

M. Vance, M. Jeffries, Mary K. Jeffries, 1992, The Journal of burn care & rehabilitation.

Clinical Aspects of Dopamine in the Regulation of Human Anterior Pituitary Function

M. Vance, M. Thorner, 1989 .

Hyperprolactinaemic infertility: some considerations on medical management

M. Vance, M. Thorner, R. Macleod, 1984 .

The Gordon Wilson Lecture. Growth hormone replacement in adults and other uses.

M. Vance, 1998, Transactions of the American Clinical and Climatological Association.

Growth and the Child with Diabetes Mellitus

W. Clarke, M. Vance, A. Rogol, 1993, Diabetes Care.

Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.

M. Vance, A. Klibanski, D. Hayden, 2002, The Journal of clinical endocrinology and metabolism.

Conventional radiotherapy for pituitary tumors.

E. Laws, M. Vance, 2000, Neurosurgery clinics of North America.

Neuroendocrine regulation of growth hormone secretion

E. Ampleford, M. Vance, M. Thorner, 1995, Neuroscience & Biobehavioral Reviews.

Therapeutic Effects of Growth Hormone Releasing Hormone

M. Vance, A. Rogol, R. Furlanetto, 1988 .

Multidisciplinary management of acromegaly: A consensus

P. Chanson, A. Mamelak, F. Casanueva, 2020, Reviews in Endocrine and Metabolic Disorders.

Medical treatment of functional pituitary tumors.

M. Vance, 2003, Neurosurgery clinics of North America.

CONSENSUS Guidelines for Acromegaly Management

P. Chanson, F. Casanueva, M. Vance, 2002 .

Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.

M. Vance, E. Laws, M. Lopes, 2001, The Journal of clinical endocrinology and metabolism.

Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly.

E. Oldfield, M. Vance, M. Molitch, 1985, The Journal of clinical endocrinology and metabolism.

Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH.

M. Vance, W. Vale, D. Kaiser, 1986, The Journal of clinical endocrinology and metabolism.

Anemia, testosterone, and pituitary adenoma in men.

D. Couture, E. Laws, M. Vance, 2003, Journal of neurosurgery.

Pituitary Function and Pathophysiology

M. Vance, I. Jialal, W. Winter, 2012 .

Growth Hormone: A Current Perspective

M. Vance, M. Thorner, B. Gaylinn, 1995 .

Actions of GRF in Man

K. Kovacs, M. Vance, A. Rogol, 1987 .

Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas

J. Sheehan, M. Vance, D. Schlesinger, 2021, Journal of Neuro-Oncology.

Therapeutic agents produced by genetic engineering: Quo vadis? The example of growth hormone and its releasing factor. Satellite symposium. Toulouse-Labège, May 29-30, 1985.

N. Ling, G. Sassolas, A. Caufriez, 1986, Hormone Research.

Physiological role of somatostatin on growth hormone regulation in humans.

E. van Cauter, M. Vance, M. Thorner, 1990, Metabolism: clinical and experimental.

Clinical Aspects of Growth Hormone Hypersecretory States

M. Vance, M. Thorner, M. Hartman, 1988 .

Growth hormone for the elderly?

M. Vance, 1990, The New England journal of medicine.

Transsphenoidal surgery for Cushing's disease: outcome in patients with a normal magnetic resonance imaging scan.

E. Laws, M. Vance, J. Findling, 2000, Neurosurgery.

Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease.

E. Laws, M. Vance, M. Locatelli, 2005, The Journal of clinical endocrinology and metabolism.

Regulation of Growth Hormone Secretion in Man

M. Vance, 1994 .

Growth Hormone‐Releasing Hormone and Growth Hormone‐Releasing Peptide as Potential Therapeutic Modalities

E. Cauter, M. Vance, A. Rogol, 1990, Acta paediatrica Scandinavica. Supplement.

Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.

M. Vance, R. Furlanetto, W. Vale, 1989, The Journal of clinical endocrinology and metabolism.

Growth-hormone-releasing hormone: a clinical update.

M. Vance, M. Thorner, 1986, Annals of internal medicine.

Growth-hormone-releasing factor.

M. Vance, A. Rogol, L. Frohman, 1983, The Lancet.

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children--2003 update.

H. Gharib, H. Rodbard, M. Vance, 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study

J. Lupski, S. Ellard, C. Stratakis, 2016, Acta neuropathologica communications.

Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study

J. Lupski, S. Ellard, C. Stratakis, 2016, Acta Neuropathologica Communications.

Cyclic Cushing syndrome: definitions and treatment implications

M. Vance, 2007 .

Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy.

Philip Smith, E. Laws, M. Vance, 2009, Journal of the American College of Surgeons.

Stereotactic radiosurgery before bilateral adrenalectomy is associated with lowered risk of Nelson’s syndrome in refractory Cushing’s disease patients

J. Sheehan, M. Vance, A. Bunevičius, 2021, Acta Neurochirurgica.

Can growth hormone prevent aging?

M. Vance, 2003, The New England journal of medicine.

Growth hormone therapy in adults and children.

M. Vance, N. Mauras, 1999, The New England journal of medicine.

The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adults.

L. Phillips, A. Hoffman, M. Vance, 2002, The Journal of clinical endocrinology and metabolism.

Clinical and reimbursement issues in growth hormone use in adults.

M. Vance, D. Cook, B. Biller, 2000, The American journal of managed care.

Neurogenic diabetes insipidus

E. Laws, M. Vance, J. Jane, 2006, Pituitary.

Transdermal testosterone treatment of hypogonadal men.

M. Vance, S. Howards, P. O. Carey, 1988, The Journal of urology.

Growth hormone therapy in adults

M. Vance, 1992, Trends in Endocrinology & Metabolism.

CV 205-502 treatment of hyperprolactinemia.

M. Vance, M. Molitch, J. R. Cragun, 1989, The Journal of clinical endocrinology and metabolism.

Growth Hormone Releasing Hormone and Growth Hormone Releasing Peptides

M. Vance, M. Thorner, M. Hartman, 1995 .

Consensus statement: medical management of acromegaly.

P. Chanson, E. Laws, F. Casanueva, 2005, European journal of endocrinology.

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline.

M. Vance, D. Clemmons, M. Molitch, 2006, The Journal of clinical endocrinology and metabolism.

Follicle-stimulating hormone- and alpha-subunit-secreting pituitary tumor treated with bromocriptine.

M. Vance, M. Thorner, E. Ridgway, 1985, The Journal of clinical endocrinology and metabolism.

Medical treatment of idiopathic infertility.

M. Vance, M. Sigman, 1987, The Urologic clinics of North America.

Amplitude suppression of the pulsatile mode of immunoradiometric luteinizing hormone release in fasting-induced hypoandrogenemia in normal men.

A. Iranmanesh, M. Vance, M. Thorner, 1993, The Journal of clinical endocrinology and metabolism.

Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline

V. Montori, M. Vance, M. Molitch, 2011, The Journal of clinical endocrinology and metabolism.

Diagnosis and complications of Cushing's syndrome: a consensus statement.

A B Atkinson, A B Grossman, G. Arnaldi, 2003, The Journal of clinical endocrinology and metabolism.

Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline.

M. Vance, A. Klibanski, M. Molitch, 1996, Journal of Clinical Endocrinology and Metabolism.

Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.

N. Pouratian, E. Laws, M. Vance, 2008, Journal of neurosurgery.

Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.

E. Laws, M. Vance, S. Lad, 2008, The Journal of clinical endocrinology and metabolism.

Gamma Knife radiosurgery for medically and surgically refractory prolactinomas: long-term results

J. Sheehan, M. Vance, D. Schlesinger, 2015, Pituitary.

Octreotide as primary therapy for acromegaly.

D. Torigian, W. Young, W. Malarkey, 1998, The Journal of clinical endocrinology and metabolism.

Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist CV 205-502.

M. Vance, A. Klibanski, M. Molitch, 1990, Annals of internal medicine.

Surgical Outcomes in Hyporesponsive Prolactinomas: Analysis of patients with Resistance or Intolerance to Dopamine Agonists

D. K. Hamilton, E. Laws, M. Vance, 2005, Pituitary.

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

J. A. Scarlett, R. K. Hutson, M. Vance, 2001, The Lancet.

Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach.

E. Laws, M. Vance, J. Jane, 2003, Neurosurgical focus.

Bromocriptine therapy for prolactin-secreting pituitary adenomas.

E. Laws, M. Vance, M. Thorner, 1996, Neurosurgical focus.

Circulating microRNA as a biomarker of human growth hormone administration to patients.

D. Bruns, M. Vance, M. Thorner, 2014, Drug testing and analysis.

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline.

M. Vance, D. Clemmons, M. Molitch, 2006, The Journal of clinical endocrinology and metabolism.

Erratum: Safety and efficacy of long term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients - A clinical research center study (Journal of Clinical Endocrinoloy and Metabolism (1995) 80 (2768-2775))

W. Young, W. Malarkey, M. Vance, 1995 .

Asian American Women: Issues, Concerns, and Responsive Human and Civil Rights Advocacy

M. Vance, 2003 .

Morbidity from paraspinal depo corticosteroid injections for analgesia: Cushing's syndrome and adrenal suppression.

M. Vance, J. M. Hughes, L. Edmonds, 1991, Anesthesia and analgesia.

Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.

E. Oldfield, M. Vance, R. Starke, 2013, The Journal of clinical endocrinology and metabolism.

Primary Hypophysitis: a Single-center Experience in 16 Cases Key Words @bullet Pituitary @bullet Hypophysitis @bullet Transsphenoidal Surgery @bullet Steroids @bullet Radiosurgery I

E. Laws, M. Vance, M. Thorner, 2022 .

Radiation therapy and stereotactic radiosurgery for the treatment of Cushing's disease: an evidence-based review

J. Sheehan, M. Vance, R. Starke, 2010, Current opinion in endocrinology, diabetes, and obesity.

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors

Julian R. E. Davis, H. Randeva, R. Eeles, 2020, The Journal of clinical endocrinology and metabolism.

Intrasellar Schwannomas: Report of Two Cases

E. Laws, M. Vance, D. Ellegala, 2003, Neurosurgery.

Double Pituitary Lesions in Three Patients with Cushing's Disease

E. Laws, B. Meij, M. Vance, 2000, Pituitary.

Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.

M L Johnson, J D Veldhuis, S M Pincus, 1994, The Journal of clinical investigation.

Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression.

E. Laws, D. Schiff, M. Vance, 2010, The Journal of clinical endocrinology and metabolism.

Gamma knife surgery for lymphocytic hypophysitis.

E. Laws, J. Sheehan, M. Vance, 2010, Journal of neurosurgery.

Outcomes of Pituitary Radiation for Cushing's Disease.

J. Sheehan, M. Vance, N. Ironside, 2018, Endocrinology and metabolism clinics of North America.

Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group.

A. Harris, M. Vance, Alan G. Harris, 1991, Archives of internal medicine.

Postoperative Management and Assessment of Cure

M. Vance, 2011 .

Gamma knife radiosurgery in patients with persistent acromegaly or Cushing's disease: long‐term risk of hypopituitarism

J. Sheehan, M. Vance, D. Schlesinger, 2016, Clinical endocrinology.

Gamma Knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy.

E. Laws, J. Sheehan, M. Vance, 2007, Journal of neurosurgery.

Hypopituitarism after Gamma Knife radiosurgery for pituitary adenomas: a multicenter, international study

John Y. K. Lee, Nathaniel D. Sisterson, D. Kondziolka, 2019, Journal of neurosurgery.

A Long-Term Study of the Treatment of Nelson's Syndrome With Gamma Knife Radiosurgery

J. Sheehan, M. Vance, Zhiyuan Xu, 2018, Neurosurgery.

Repeat stereotactic radiosurgery for Cushing’s disease: outcomes of an international, multicenter study

Nathaniel D. Sisterson, L. Lunsford, J. Sheehan, 2018, Journal of Neuro-Oncology.

Stereotactic Radiosurgery for Cushing's Disease: Results of an International, Multicenter Study

John Y. K. Lee, Nathaniel D. Sisterson, D. Kondziolka, 2017, Journal of Neurological Surgery Part B: Skull Base.

Results of gamma knife surgery for Cushing's disease.

Paul J. Schmitt, J. Sheehan, M. Vance, 2013, Journal of neurosurgery.

Effect of stereotactic radiosurgery before bilateral adrenalectomy for Cushing's disease on the incidence of Nelson's syndrome.

J. Sheehan, M. Vance, Gautam U. Mehta, 2013, Journal of neurosurgery.

Gamma Knife surgery for Cushing's disease.

N. Pouratian, E. Laws, J. Sheehan, 2007, Journal of neurosurgery.

OUTCOMES AFTER REPEAT TRANSSPHENOIDAL SURGERY FOR RECURRENT CUSHING'S DISEASE

E. Laws, M. Vance, D. Prevedello, 2008, Neurosurgery.

Hypopituitarism: Differential Diagnosis and Treatment

M. Vance, 1997 .

Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.

N. Pouratian, E. Laws, M. Vance, 2007, The Journal of clinical endocrinology and metabolism.

Single-center experience with pediatric Cushing's disease.

Adam S. Kanter, D. Okonkwo, E. Laws, 2005, Journal of neurosurgery.

Hypophysitis

John A. Jane, M. Vance, Edward R. Laws, 2006, Pituitary.

Pituitary adenoma: a clinician's perspective.

M. Vance, 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The Role of Brain Dopamine

J. C. Stoof, J. Kornhuber, P. Riederer, 1989, Basic and Clinical Aspects of Neuroscience.

: The Strategy of Immediate Reoperation for Transsphenoidal Surgery for Cushing ’ s Disease

E. Laws, M. Vance, M. Locatelli, 2005 .

Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study

John Y. K. Lee, Nathaniel D. Sisterson, D. Kondziolka, 2019, Neurosurgery.

Gamma Knife Radiosurgery for Medically and Surgically Refractory Prolactinomas

N. Pouratian, E. Laws, J. Sheehan, 2006, Neurosurgery.

Gamma surgery in the treatment of nonsecretory pituitary macroadenoma.

E. Laws, J. Sheehan, M. Vance, 2006, Journal of neurosurgery.

The Transsphenoidal Transtuberculum Sellae Approach for Suprasellar Meningiomas

E. Laws, M. Vance, A. Dumont, 2003 .

Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.

D. Kondziolka, L. Lunsford, B. Zacharia, 2021, Journal of Neurosurgery.

Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large, multigenerational kindred.

M. Vance, J. Carpenter, C. Stolle, 1998, The Journal of clinical endocrinology and metabolism.

Stereotactic radiosurgery for acromegaly.

J. Sheehan, M. Vance, D. Schlesinger, 2014, The Journal of clinical endocrinology and metabolism.

Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.

D L Kaiser, M. Vance, R. Furlanetto, 1985, The Journal of clinical investigation.

Treatment of patients with a pituitary adenoma: one clinician's experience.

M. Vance, 2004, Neurosurgical focus.

CLINICAL PRACTICE GUIDELINE Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline

M. Vance, D. Clemmons, M. Molitch, 2006 .

Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome.

E. Laws, M. Vance, R. Starke, 2011, The Journal of clinical endocrinology and metabolism.

Surgical and radiosurgical treatment strategies for Cushing’s disease

E. Laws, J. Sheehan, M. Vance, 2019, Journal of Neuro-Oncology.

Endocrine Remission After Pituitary Stereotactic Radiosurgery: Differences in Rates of Response for Matched Cohorts of Cushing Disease and Acromegaly Patients.

J. Sheehan, M. Vance, A. Quiñones‐Hinojosa, 2018, International journal of radiation oncology, biology, physics.

Perioperative management of patients undergoing pituitary surgery.

M. Vance, 2003, Endocrinology and metabolism clinics of North America.

Quality of Life in Patients with a Pituitary Adenoma

M. Vance, C. Woodburn, Michelle D. Johnson, 2003, Pituitary.

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update: executive summary of recommendations.

M. Vance, K. Yuen, D. Cook, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Radiosurgery for pituitary tumors and craniopharyngiomas.

E. Laws, M. Vance, 1999, Neurosurgery clinics of North America.

GAMMA KNIFE RADIOSURGERY FOR ACROMEGALY: OUTCOMES AFTER FAILED TRANSSPHENOIDAL SURGERY

N. Pouratian, E. Laws, J. Sheehan, 2008, Neurosurgery.

Clinical Characteristics of Silent Corticotrophic Adenomas and Creation of an Internet-accessible Database to Facilitate Their Multi-institutional Study

D. Okonkwo, E. Laws, M. Vance, 2003, Neurosurgery.

A cryptic cause of Cushing's disease.

E. Oldfield, M. Vance, 2013, The Journal of clinical endocrinology and metabolism.

Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.

D. Okonkwo, E. Laws, M. Vance, 2005, Journal of neurosurgery.

Effective time window in reducing pituitary adenoma size by gamma knife radiosurgery

M. Wintermark, W. Qian, H. Mak, 2015, Pituitary.

Routine postoperative fluid restriction to prevent syndrome of inappropriate antidiuretic hormone secretion after transsphenoidal resection of pituitary adenoma.

M. Vance, J. Jane, D. Asuzu, 2021, Journal of neurosurgery.

Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes.

N. Pouratian, E. Laws, J. Sheehan, 2011, Journal of neurosurgery.

HUMAN PANCREATIC GROWTH-HORMONE-RELEASING FACTOR SELECTIVELY STIMULATES GROWTH-HORMONE SECRETION IN MAN

M. Vance, A. Rogol, W. Vale, 1983, The Lancet.

The neurosurgical management of Cushing's disease

E. Laws, M. Vance, M. Reitmeyer, 2002, Molecular and Cellular Endocrinology.

4 – The Perioperative Care of the Pituitary Patient

E. Laws, M. Vance, D. Ellegala, 2010 .

Nonfunctioning pituitary adenoma.

M. Vance, 1997, Current therapy in endocrinology and metabolism.

Current Status and Future Opportunities for Controlling Acromegaly

M. Vance, S. Melmed, A. Klibanski, 2004, Pituitary.

Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.

E. Oldfield, M. Vance, M. Lopes, 2015, The Journal of clinical endocrinology and metabolism.

Reversibility of gastric dysmotility in cortisol deficiency.

M. Vance, R. McCallum, W. Smalley, 1987, The American journal of gastroenterology.

Characterization of a paradoxical post-operative increase in serum cortisol in Cushing disease

M. Vance, N. Ironside, Kathryn N. Kearns, 2022, Pituitary.

AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly.

S. Ezzat, M. Vance, D. Cook, 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion.

M. Vance, D. Moller, A. Moses, 1989, The Journal of clinical endocrinology and metabolism.

Growth hormone, 1988.

M. Vance, M. Thorner, 1988, The Journal of clinical investigation.

142 Stereotactic Radiosurgery for Medically and Surgically Refractory Acromegaly: Long-term Rates of Remission and Hypopituitarism

J. Sheehan, M. Vance, D. Schlesinger, 2015 .

From Fixed to Individual Dosing in Growth Hormone-Deficient Adults

M. Vance, 2001, Hormone Research in Paediatrics.

Pulmonary Tumor Embolism Diagnosed by Endobronchial Ultrasound

K. Kovitz, M. Vance, Sara R Greenhill, 2011, Journal of bronchology & interventional pulmonology.

Cushing’s disease: radiation therapy

M. Vance, 2008, Pituitary.

Analysis of 445 Patients with Cushing???s Disease Treated by Transsphenoidal Surgery: 898

N. Pouratian, E. Laws, M. Vance, 2006 .

Circulating growth hormone forms after stimulation of pituitary secretion with growth hormone-releasing factor in man.

M. Vance, M. Stolar, M. Thorner, 1984, The Journal of clinical endocrinology and metabolism.

Growth hormone and nutrition.

M. Vance, M. Thorner, M. Hartman, 1992, Hormone research.

Human pancreatic tumor GH-releasing factor

M. Vance, A. Rogol, L. Frohman, 2005, Acta Neurochirurgica.

Case 6-2013: Perioperative management of an adult patient with tetralogy of fallot and pheochromocytoma.

M. Vance, B. Kussman, Yee Kwan Tang, 2013, Journal of cardiothoracic and vascular anesthesia.

Serving Wounded Warriors: Current Practices in Postsecondary Education.

M. Vance, W. Miller, 2009 .

Contemporary tools for the analysis of episodic growth hormone secretion and clearance in vivo.

M. Vance, M. Thorner, J. Veldhuis, 1988, Acta paediatrica Scandinavica. Supplement.

The Baromodulatory Effect of Gamma Knife Irradiation of the Hypothalamus in the Obese Zucker Rat

Beatrice Lopez, M. Vance, D. Ellegala, 2005, Stereotactic and Functional Neurosurgery.

Cushing's disease resulting from pituitary corticotrophic microadenoma. Treatment results from transsphenoidal microsurgery and gamma knife radiosurgery.

E. Laws, M. Vance, K. Thapar, 2002, Neuro-Chirurgie.

Plasma transport of human growth hormone in vivo.

M. Vance, M. Thorner, M. Shaw, 1990, The Journal of clinical endocrinology and metabolism.

Inferior Petrosal Sinus Sampling in the Differential Diagnosis of ACTH-Dependent Cushing’s Syndrome

M. Vance, C. McCartney, 2001 .

Preparing for the Future IT Era: Perceptions of Students with Disabilities about IT Training in South Korea.

M. Vance, Jiyoung Son, Dongil Kim, 2012 .

Radiosurgery Practice Guideline Initiative Stereotactic Radiosurgery for Patients with

L. Lunsford, J. Buatti, J. Knisely, 2004 .

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.

W. Young, W. Malarkey, M. Vance, 1995, The Journal of clinical endocrinology and metabolism.

The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adults.

L. Phillips, M. Vance, A. Illeperuma, 2002, The Journal of clinical endocrinology and metabolism.

Veterans with Disabilities in Postsecondary Education.

M. Vance, Joseph W. Madaus, W. Miller, 2009 .

Octreotide treatment of acromegaly. A randomized, multicenter study.

W. Young, S. Ezzat, M. Vance, 1992, Annals of internal medicine.

Gamma Knife Radiosurgery for Secretory Pituitary Adenomas

E. Laws, M. Vance, 2003 .

Silent Corticotroph Staining Pituitary Neuroendocrine Tumors: Prognostic Significance in Radiosurgery

D. Kondziolka, L. Lunsford, R. Warnick, 2023, Neurosurgery.

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline.

M. Vance, D. Clemmons, M. Molitch, 2006, The Journal of clinical endocrinology and metabolism.

Pulmonary Tumor Embolism Diagnosed by Endobronchial Ultrasound

K. Kovitz, M. Vance, Sara R Greenhill, 2015, Journal of bronchology & interventional pulmonology.

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline.

M. Vance, D. Clemmons, M. Molitch, 2006, The Journal of clinical endocrinology and metabolism.

Post-Operative Serum Cortisol and Cushing Disease Recurrence in Patients with Corticotroph Adenomas.

M. Vance, N. Ironside, Kathryn N. Kearns, 2023, The Journal of clinical endocrinology and metabolism.

Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach.

E. Laws, M. Vance, J. Jane, 2003, Neurosurgical focus.

Quantification of growth hormone mRNA in blood.

D. Bruns, M. Vance, M. Thorner, 2012, Clinica chimica acta; international journal of clinical chemistry.

Diagnosis, Management, and Prognosis of Pituitary Tumors

M. Vance, 2001 .

Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly

P. Cappabianca, A. Mamelak, R. Fahlbusch, 2017, Pituitary.

Hypopituitarism: Differential Diagnosis and Treatment

M. Vance, 1997 .

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.

M. Vance, K. Yuen, D. Cook, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.